Postes actifs de Peter Alff
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Directeur/Membre du Conseil | - | - |
Opera Therapeutics, Inc.
 Opera Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Opera Therapeutics, Inc. develops next-generation treatments therapeutics for ocular and neurological diseases. The company was founded in 2017 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - | - |
| President | - | - | |
Symbiotix Biotherapies, Inc.
 Symbiotix Biotherapies, Inc. BiotechnologyHealth Technology Symbiotix Biotherapies, Inc. develops a novel class of molecular therapeutics based on the human microbiome. It delivers first-in-class oral agents that improve the lives of patients with inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases. The company was founded by Lloyd Kasper, Nader Yaghoubi, Sarkis Mazmanian and Dennis Kasper in 2009 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Peter Alff
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Director/Board Member | 3 |
| President | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Opera Therapeutics, Inc.
Opera Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Opera Therapeutics, Inc. develops next-generation treatments therapeutics for ocular and neurological diseases. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Symbiotix Biotherapies, Inc.
Symbiotix Biotherapies, Inc. BiotechnologyHealth Technology Symbiotix Biotherapies, Inc. develops a novel class of molecular therapeutics based on the human microbiome. It delivers first-in-class oral agents that improve the lives of patients with inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases. The company was founded by Lloyd Kasper, Nader Yaghoubi, Sarkis Mazmanian and Dennis Kasper in 2009 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Peter Alff
- Expérience
